| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |